April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- One in two chronically ill patients report difficulties in accessing care, according to a survey Nov 15, 2022
- Named the eating habits of healthy people May 7, 2020
- Named products that help to liquefy thick blood May 23, 2020
- Covid-19: After a brief lull, the coronavirus epidemic is starting again in France Nov 25, 2022
- Covid, Zangrillo: “Young Italians will teach us a lesson by getting vaccinated” Jul 25, 2021
- Covid today Russia, 18,645 infections: exceeded 7 million in total Sep 5, 2021
- Cardiovascular risk factors in childhood affect cognition May 29, 2021
Maxie Eckert
Today at 11:34 AM
.
